Danielle R. Tilmanis

792 Elizabeth St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.

Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.

Journal: Communications medicine

Published: November 21, 2024

Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.

Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.

Journal: Antiviral research

Published: January 01, 2020

Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.

Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.

Journal: Antiviral research

Published: October 24, 2019

Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment.

Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: January 24, 2019

Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.

Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.

Journal: Antiviral research

Published: November 30, 2018

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.

Journal: The Journal of clinical investigation

Published: July 06, 2018

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.

Journal: Nature communications

Published: May 30, 2018

The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.

The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.

Journal: Antiviral research

Published: August 11, 2017

Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.

Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.

Journal: Vaccine

Published: February 02, 2017

Influenza antivirals currently in late-phase clinical trial.

Influenza antivirals currently in late-phase clinical trial.

Journal: Influenza and other respiratory viruses

Published: January 26, 2017

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Journal: JCI insight

Published: January 09, 2017

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Journal: Antiviral research

Published: April 11, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026